Wysa receives USFDA approval for AI led device for mental health – ET HealthWorld
Bangalore: Wysa, an artificial intelligence (AI)-based platform for behavioural health, has announced that the United States Food and Drug Administration (FDA) has granted breakthrough device designation for its AI-based digital mental health conversational agent for patients 18 years and older with a diagnosis of chronic musculoskeletal pain, depression and anxiety. The device delivers cognitive behavioural … Read more